| Pharmaceutical active ingredients: |
| Pegfilgrastim |
| Available forms, composition and doses of Neulasta: |
| Injectable; Injection; Pegfilgrastim 10 mg / mlInjectable; Injection; Pegfilgrastim 6 mg / ml |
| Neulasta medical category: |
| Human:Hematopoietic agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L03AA13 - Pegfilgrastim |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| AmgenGenesis PharmaceuticalsUnited Drug |
| Related documents and information about Neulasta: |
| Neulasta prescribing information (PDF) |